Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

338.10
Delayed Data
As of Oct 20
 -4.32 / -1.26%
Today’s Change
244.28
Today|||52-Week Range
348.84
+29.44%
Year-to-Date

Today’s Trading

Previous close342.42
Today’s open343.00
Day’s range333.93 - 343.31
Volume1,909,267
Average volume (3 months)1,364,994
Market cap$71.5B
Dividend yield--
Data as of 10/20/2017

Growth & Valuation

Earnings growth (last year)+10.32%
Earnings growth (this year)+6.49%
Earnings growth (next 5 years)+5.71%
Revenue growth (last year)+9.37%
P/E ratio22.2
Price/Sales6.09
Price/Book6.01

Competitors

 Today’s
change
Today’s
% change
ILMNIllumina Inc+4.70+2.29%
GILDGilead Sciences-0.38-0.47%
----
BIVVBioverativ Inc+0.49+0.82%
Data as of 10/20/2017

Financials

Next reporting dateOctober 24, 2017
EPS forecast (this quarter)$5.70
Annual revenue (last year)$10.2B
Annual profit (last year)$3.7B
Net profit margin36.32%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michel Vounatsos
Senior Vice President-
US Therapeutic Operations
Alisha A. Alaimo
Corporate headquarters
Cambridge, Massachusetts

Forecasts